Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients.
Claassens DMF, Gimbel ME, Bergmeijer TO, Vos GJA, Hermanides RS, van der Harst P, Barbato E, Morisco C, Tjon Joe Gin RM, de Vrey EA, Heestermans TACM, Jukema JW, von Birgelen C, Waalewijn RA, Hofma SH, den Hartog FR, Voskuil M, Van't Hof AWJ, Asselbergs FW, Mosterd A, Herrman JR, Dewilde W, Mahmoodi BK, Deneer VHM, Ten Berg JM. Claassens DMF, et al. Among authors: mosterd a. Int J Cardiol. 2021 Jul 1;334:10-17. doi: 10.1016/j.ijcard.2021.04.029. Epub 2021 Apr 20. Int J Cardiol. 2021. PMID: 33887342
Amiodarone for prevention of atrial fibrillation.
van 't Hof AW, Mosterd A, Suttorp MJ. van 't Hof AW, et al. Among authors: mosterd a. Am J Cardiol. 1996 Feb 1;77(4):327. doi: 10.1016/s0002-9149(97)89413-1. Am J Cardiol. 1996. PMID: 8607427 No abstract available.
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
ten Berg JM, van 't Hof AW, Dill T, Heestermans T, van Werkum JW, Mosterd A, van Houwelingen G, Koopmans PC, Stella PR, Boersma E, Hamm C; On-TIME 2 Study Group. ten Berg JM, et al. Among authors: mosterd a. J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091. J Am Coll Cardiol. 2010. PMID: 20510211 Free article. Clinical Trial.
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
Heestermans T, van 't Hof AW, ten Berg JM, van Werkum JW, Boersma E, Mosterd A, Stella PR, van Zoelen AB, Gosselink AT, Kochman W, Dill T, Koopmans PC, van Houwelingen G, Zijlstra F, Hamm C. Heestermans T, et al. Among authors: mosterd a. Am Heart J. 2010 Dec;160(6):1079-84. doi: 10.1016/j.ahj.2010.08.039. Am Heart J. 2010. PMID: 21146661 Clinical Trial.
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.
Heestermans T, Suryapranata H, ten Berg JM, Mosterd A, Gosselink AT, Kochman W, Dill T, van Houwelingen G, Kolkman E, van Werkum JW, Zijlstra F, Hamm C, van 't Hof AW. Heestermans T, et al. Among authors: mosterd a. J Electrocardiol. 2011 Jan-Feb;44(1):42-8. doi: 10.1016/j.jelectrocard.2010.09.010. J Electrocardiol. 2011. PMID: 21168000 Clinical Trial.
Higher efficacy of pre-hospital tirofiban with longer pre-treatment time to primary PCI: protection for the negative impact of time delay.
Heestermans T, de Boer MJ, van Werkum JW, Mosterd A, Gosselink AT, Dambrink JH, van Houwelingen G, Koopmans P, Hamm C, Zijlstra F, ten Berg JM, van 't Hof AW. Heestermans T, et al. Among authors: mosterd a. EuroIntervention. 2011 Aug;7(4):442-8. doi: 10.4244/EIJV7I4A73. EuroIntervention. 2011. PMID: 21764662 Free article. Clinical Trial.
Fast assessment and management of chest pain without ST-elevation in the pre-hospital gateway: rationale and design.
Ishak M, Ali D, Fokkert MJ, Slingerland RJ, Dikkeschei B, Tolsma RT, Lichtveld RA, Bruins W, Boomars R, Bruheim K, van Eenennaam F, Timmers L, Voskuil M, Doevendans PA, Mosterd A, Hoes AW, ten Berg JM, van 't Hof AW; FAMOUS TRIAGE Study Group. Ishak M, et al. Among authors: mosterd a. Eur Heart J Acute Cardiovasc Care. 2015 Apr;4(2):129-36. doi: 10.1177/2048872614549738. Epub 2014 Sep 8. Eur Heart J Acute Cardiovasc Care. 2015. PMID: 25202026 Clinical Trial.
Suspected acute coronary syndrome in the emergency room: Limited added value of heart type fatty acid binding protein point of care or ELISA tests: The FAME-ER (Fatty Acid binding protein in Myocardial infarction Evaluation in the Emergency Room) study.
Bank IE, Dekker MS, Hoes AW, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, Timmers L, de Kleijn DP, Glatz JF, Mosterd A. Bank IE, et al. Among authors: mosterd a. Eur Heart J Acute Cardiovasc Care. 2016 Aug;5(4):364-74. doi: 10.1177/2048872615584077. Epub 2015 Apr 23. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25906779
176 results